JINARC TABLET 45MG/15MG
Product details
Registration number: SIN16609P
Classification: Prescription Only
Active ingredients:
- (15mg Tablet) Tolvaptan
- (45mg Tablet) Tolvaptan
Strength:
- 15.000mg
- 45.0mg
Dosage form: TABLET
Route: ORAL
Registrant: OTSUKA PHARMACEUTICALS (SINGAPORE) PTE. LTD.
ATC code: C03XA01
HSA approval date: 23 September 2022
Manufacturer(s):
- Otsuka Pharmaceutical Co., Ltd. - Tokushima Factory (DP intermediate)
- Otsuka Pharmaceutical Co., Ltd. - Tokushima Itano Factory
- AndersonBrecon (UK) Ltd. (Primary and Secondary Packager)
Manufacturing country/countries: UNITED KINGDOM; JAPAN
What are the HSA registration number and classification for JINARC TABLET 45MG/15MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16609P
Classification: Prescription Only
What active ingredients and strength are recorded for JINARC TABLET 45MG/15MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- (15mg Tablet) Tolvaptan
- (45mg Tablet) Tolvaptan
Strength:
- 15.000mg
- 45.0mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for JINARC TABLET 45MG/15MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET
Route: ORAL
Who is the recorded registrant for JINARC TABLET 45MG/15MG?
According to the HSA dataset updated 7 August 2026:
Registrant: OTSUKA PHARMACEUTICALS (SINGAPORE) PTE. LTD.
Which manufacturers and countries are listed for JINARC TABLET 45MG/15MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Otsuka Pharmaceutical Co., Ltd. - Tokushima Factory (DP intermediate)
- Otsuka Pharmaceutical Co., Ltd. - Tokushima Itano Factory
- AndersonBrecon (UK) Ltd. (Primary and Secondary Packager)
Manufacturing country/countries: UNITED KINGDOM; JAPAN
Where can I look up JINARC TABLET 45MG/15MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16609P or the exact product name JINARC TABLET 45MG/15MG. The general register link does not preselect this product.
What are the source dates for this JINARC TABLET 45MG/15MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this JINARC TABLET 45MG/15MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16609P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)